Trial updateOphthalmology
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
Recruiting. Phase 1. Registered enrolment: 30. Hoffmann-La Roche
Why it matters
Track this study through NCT07588100. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 1
- Registered enrolment
- 30
- Results posted
- No
- Sponsor
- Hoffmann-La Roche
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.